Qingxin Zhou#, Meihua Lin#, Xing Feng#, Fei Ma#, Yuekun Zhu, Xing Liu, Chao Qu, Hong Sui, Bei Sun, Anlong Zhu, Heng Zhang, He Huang, Zhi Gao, Yongxiang Zhao, Jiangyun Sun, Yuxian Bai, Junfei Jin*, Xuehui Hong*, Chang Zou*, Zhiyong Zhang*. Targeting CLK3 Inhibits the Progression of Cholangiocarcinoma by Reprogramming Nucleotide Metabolism. J Exp Med, 2020, 217(8):e20191779. (SCI, JCR1, Nature Index, IF: 10.892)
发布时间：2020-06-16
点击次数：
是否译文：否
附件：
上一条： Zhengjun Lin, Shiyao Lu, Xubin Xie, Xuyang Yi, He Huang. Noncoding RNAs in drug-resistant pancreatic cancer: A review. Biomed Pharmacother, 2020, 131, 110768. (SCI, JCR2, IF: 6.529)
下一条： Heng Zhang, He Huang*, Xing Feng, Huiwen Song, Zhiyong Zhang*, Aizong Shen*, Xingfeng Qiu*. Deubiquitinase USP28 inhibits ubiquitin ligase KLHL2-mediated uridine-cytidine kinase 1 degradation and confers sensitivity to 5'-azacytidine-resistant human leukemia cells. Theranostics, 2020, 10(3):1046-1059. (SCI, JCR1, IF: 8.063)